Analyst firms · Guggenheim · TVTX

Guggenheim TVTX price target and rating history

Travere Therapeutics Inc. (TVTX) · Health Care

Guggenheim rates Travere Therapeutics Inc. (TVTX) Buy with a $25 price target, as of its latest action on Sep 9, 2024. It has published 3 rating actions on TVTX since March 2023, including 1 upgrade and 1 downgrade.

Current rating
Buy
Price target
$25
Median target, all firms
Too few
Actions on TVTX
3

Guggenheim price target on TVTX

$37$31$25202420252026
Guggenheim price target on TVTX, each point a stated target, March 2023 to September 2024.

Every Guggenheim rating on TVTX

Questions about Guggenheim and TVTX

What is Guggenheim's price target for TVTX?
Guggenheim's latest stated price target for Travere Therapeutics Inc. (TVTX) is $25, from its action on Sep 9, 2024.
What is Guggenheim's rating on TVTX?
Guggenheim rates TVTX Buy, a bullish rating, as of Sep 9, 2024.
When did Guggenheim last change its view on TVTX?
On Sep 9, 2024, Guggenheim upgrades to Buy from Neutral, price target $25.

More TVTX rating histories

All Guggenheim ratingsTVTX news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.